Jayasree K. Iyer, CEO of Access to Medicine Foundation, moderated a panel discussion that featured leaders from the 2024 Access to Medicine Index. Jayasree highlighted how biopharma companies foster accessibility to essential medicines in low- and middle-income countries through global partnerships, innovation, and sustainable models.
Jayasree talks about the future of Health Equity amidst the evolving healthcare landscape, regulatory restrictions, and growing geopolitical tensions.
Image Source: Canva
About the Author:
Jayasree Iyer
As CEO, Jayasree K. Iyer sets the Foundation’s strategy for assessing the efforts of healthcare companies to ensure their products reach more people around the world. In her discussions with global industry leaders, she engages them on the practical, effective steps they can take to develop, scale up and supply essential health products to the people living in low- and middle-income countries (LMICs) who account for approximately 80% of the global population.
Related Post: Reuters Pharma 2025: Post-Conference Talks Featuring Hector De La Riva
